002727 Stock Overview
Together with its subsidiary, operates a chain of drugstores in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Yixintang Pharmaceutical Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥19.01 |
| 52 Week High | CN¥22.32 |
| 52 Week Low | CN¥10.84 |
| Beta | 0.78 |
| 1 Month Change | 43.47% |
| 3 Month Change | 45.67% |
| 1 Year Change | -13.67% |
| 3 Year Change | -11.66% |
| 5 Year Change | -38.48% |
| Change since IPO | 116.39% |
Recent News & Updates
Recent updates
Yixintang Pharmaceutical Group (SZSE:002727) Has A Pretty Healthy Balance Sheet
Mar 21
Calculating The Fair Value Of Yixintang Pharmaceutical Group Co., Ltd. (SZSE:002727)
Dec 12Yixintang Pharmaceutical Group (SZSE:002727) Might Be Having Difficulty Using Its Capital Effectively
Nov 22Yixintang Pharmaceutical Group's (SZSE:002727) Soft Earnings Are Actually Better Than They Appear
Nov 06Market Cool On Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Earnings
Sep 25These 4 Measures Indicate That Yixintang Pharmaceutical Group (SZSE:002727) Is Using Debt Reasonably Well
Jul 15Some Investors May Be Worried About Yixintang Pharmaceutical Group's (SZSE:002727) Returns On Capital
Jun 29Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Intrinsic Value Is Potentially 26% Below Its Share Price
Jun 13Market Cool On Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Earnings Pushing Shares 27% Lower
Jun 13Yixintang Pharmaceutical Group (SZSE:002727) Is Due To Pay A Dividend Of CN¥0.40
May 27Yixintang Pharmaceutical Group's (SZSE:002727) Conservative Accounting Might Explain Soft Earnings
May 03Investors Holding Back On Yixintang Pharmaceutical Group Co., Ltd. (SZSE:002727)
Apr 15Return Trends At Yixintang Pharmaceutical Group (SZSE:002727) Aren't Appealing
Mar 06Shareholder Returns
| 002727 | CN Consumer Retailing | CN Market | |
|---|---|---|---|
| 7D | 38.0% | 1.6% | 0.1% |
| 1Y | -13.7% | 12.6% | 9.4% |
Return vs Industry: 002727 underperformed the CN Consumer Retailing industry which returned 12.6% over the past year.
Return vs Market: 002727 underperformed the CN Market which returned 9.4% over the past year.
Price Volatility
| 002727 volatility | |
|---|---|
| 002727 Average Weekly Movement | 6.3% |
| Consumer Retailing Industry Average Movement | 7.1% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in CN Market | 10.2% |
| 10% least volatile stocks in CN Market | 4.3% |
Stable Share Price: 002727 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002727's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 36,447 | Yong Zhang | www.hx8886.com |
Yixintang Pharmaceutical Group Co., Ltd., together with its subsidiary, operates a chain of drugstores in China. It also produces and sells medicinal materials, Chinese herbal medicines, and food and health products, as well as engages in the drug distribution activities. It operates stores in Yunnan, Guizhou, Guangxi, Sichuan, Shanxi, Chongqing, Tianjin, Shanghai, Qiong, and other provinces and municipalities.
Yixintang Pharmaceutical Group Co., Ltd. Fundamentals Summary
| 002727 fundamental statistics | |
|---|---|
| Market cap | CN¥9.92b |
| Earnings (TTM) | CN¥32.29m |
| Revenue (TTM) | CN¥17.67b |
Is 002727 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002727 income statement (TTM) | |
|---|---|
| Revenue | CN¥17.67b |
| Cost of Revenue | CN¥12.13b |
| Gross Profit | CN¥5.54b |
| Other Expenses | CN¥5.51b |
| Earnings | CN¥32.29m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.056 |
| Gross Margin | 31.37% |
| Net Profit Margin | 0.18% |
| Debt/Equity Ratio | 21.4% |
How did 002727 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/23 08:36 |
| End of Day Share Price | 2025/05/23 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Yixintang Pharmaceutical Group Co., Ltd. is covered by 16 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Haigang Chen | China International Capital Corporation Limited |
| Zhu Chen | Citic Securities Co., Ltd. |
| Yonglin Yan | CLSA |